PPARγ gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus
<p>Abstract</p> <p>Background</p> <p>Peroxisome proliferator-activated receptor γ (PPARγ) is a ligand-activated transcription factor, which regulates gene expression of the key proteins involved in lipid metabolism, vascular inflammation, and proliferation. PPARγ may co...
Main Authors: | Wang Jinghua, Ma Yexin, Xiao Jianming, Chao Shengping, Xiong Shixi, Wan Jing, Roy Sabita |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-03-01
|
Series: | Cardiovascular Diabetology |
Online Access: | http://www.cardiab.com/content/9/1/13 |
Similar Items
-
The Association of PPARγ Pro12Ala and C161T Polymorphisms with Polycystic Ovary Syndrome and Their Influence on Lipid and Lipoprotein Profiles
by: Zohreh Rahimi, et al.
Published: (2018-07-01) -
Lipid metabolome-wide effects of the PPARγ agonist rosiglitazones⃞
by: Steven M. Watkins, et al.
Published: (2002-11-01) -
Control of brown adipose tissue glucose and lipid metabolism by PPARγ
by: William T. Festuccia, et al.
Published: (2011-12-01) -
PPARadigms and PPARadoxes: expanding roles for PPARγ in the control of lipid metabolism
by: Robert Walczak, et al.
Published: (2002-02-01) -
Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
by: Ajit A. Kulkarni, et al.
Published: (2012-01-01)